30 Day Trial

BARE BONES content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Product / Company Performance

OrthoPediatrics Announces 2Q18 Revenue -

OrthoPediatrics (KIDS) posted 2Q18 revenue of US $15.1MM, +27.8% vs. 2Q17, and 1H18 revenue of $27.2MM, +26.0% vs. 1H17.

  2Q18  2Q17  $ Change  % Change 
 Trauma $9.9  $7.9  $2.0  25.3% 
 Spine $4.9  $3.4  $1.5  42.7% 
 Arthroscopy/Soft Tissue Repair $0.3  $0.5  -$0.2  -36.3% 
Total  $15.1  $11.8  $3.3  27.8% 


  1H18  1H17  $ Change  % Change 
 Trauma  $19.0  $15.6  $3.4  21.6% 
 Spine $7.6  $5.4  $2.2  41.6% 
 Arthroscopy/Soft Tissue Repair $0.6  $0.6  $0.0  0.7% 
Total  $27.2  $21.6  $5.6  26.0% 


Revenue by geographic region:

  2Q18 1H18
 U.S. $11.5 $20.1
 Ex-U.S. $3.6 $7.1


This is KIDS’ highest reported quarterly revenue ever. While Arthroscopy/Soft Tissue Repair is a very small portion of revenue, no explanation was given for the drop in growth.

KIDS continues to invest in consignment sets, R&D and salesforce expansion. They invested an additional $2.8MM in sets in the quarter, and remain on track to end the year having invested $11.0MM in total. (This is up from the $10.0MM cited in the 1Q earnings call.)

Thirteen domestic reps came on board in 2Q. Four additional systems will launch by year end, including the small stature RESPONSE scoliosis system and an additional BandLok device. R&D is said to be making progress on active growing implants and spinal tethering.

The company raised full-year revenue guidance from +22% vs. 2017; the range is now +23% to +%24% for upwards of $42.0MM.

Source: OrthoPediatrics, Inc.

This article is a Member-only item of content. Members, please log in to read the complete post.
If you are not yet a Member, click here to learn more about purchasing ORTHOWORLD Membership.